‘An unprecedented year of new buildings’ at USC

USC News looks back on the year in construction at USC, highlighting the USC Village and Michelson Hall, home of the USC Michelson Center for Convergent Bioscience, as two projects that “will leave lasting impacts on future generations of Trojans and scientific research.” (December 26, 2017)

How a tumor grows can predict response to cancer therapy

USC Viterbi News writes about a new study out of the USC Viterbi School of Engineering that finds tumor growth properties can influence response to cancer drugs. “Identifying a measurement or quantity that predicts how specific tumors will respond, called a predictive biomarker, is extremely valuable to cancer research,” said Stacey Finley, a USC assistant professor of Biomedical Engineering, co-author to the study, the Gordon S. Marshall Early Career Chair, and a faculty member at the USC Michelson Center for Convergent Bioscience. (December 21, 2017)

Michelson Center researchers advance work on nonaddictive opioid painkiller

USC News writes: “What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects? That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience … The findings were published Jan. 4 in the journal Cell. They are an example of how USC Michelson Center scientists collaborate with a range of experts in multiple disciplines to conduct groundbreaking research.” (January 4, 2018)

Viterbi Researchers Design Thermal ‘Skin’ to Maintain Temperature of Satellites

USC Viterbi writes that a team of USC researchers that developed a new material to self-regulate the temperature of a satellite, working in conjunction with a team at Northrop Grumman, will benefit from “the new capabilities in the recently-dedicated John D. O’Brien Nanofabrication Laboratory in the USC Michelson Center for Convergent Bioscience.”

Calling on students to develop fresh approaches to total patient care

The USC Iovine and Young Academy announced a grant from the Phase ONE Foundation that will initiate a full-scale, four-year undergraduate track focused on health innovation to help patients achieve better outcomes, anticipated to launch in fall 2019. Since last year, students have been working with USC’s Convergent Science Initiative in Cancer led by Peter Kuhn, a faculty member at the USC Michelson Center for Convergent Bioscience and dean’s professor at the USC Dornsife College of Letters, Arts and Sciences, to “hack cancer,” as Kuhn puts it. (November 30, 2017)

Forbes: “USC Sees The Future With New Course Offering”

Forbes writes that “It’s hard to over-stress how big a breakthrough this USC IP course is. Until recently, intellectual property had been taught only in law schools or the occasional business school seminar.” The outlet notes that for Dr. Gary Michelson, the course “helps fulfil a promise he made to his crippled grandmother half a century ago to find cures for disease.” (November 9, 2017)